ARCHIVES

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

December 26, 2008

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003

Professional Issues: AMA Identifies Tobacco-Free Mutual Funds

February 21, 1997

Oncology ManagementL AOR earns $30 Million, PRN Earns $29.8 Million

March 5, 1999

NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”

May 7, 1993

Funding Opportunities: NIH Creates Awards For Clinical Research

March 27, 1998